Morbid Obesity Treatment in United Arab Emirates

What is Morbid Obesity?

Severe or morbid obesity, also known as class III obesity, is a chronic condition involving excess body fat that can significantly affect health and daily functioning. In adults, it is commonly defined as a body mass index (BMI) of 40 kg/m² or higher. BMI is a screening measure and does not fully reflect body composition, fat distribution, or individual health risk, so clinicians also consider waist circumference, metabolic health, functional status, and obesity-related complications. Severe obesity can increase the risk of conditions such as type 2 diabetes, cardiovascular disease, obstructive sleep apnoea, fatty liver disease, osteoarthritis, and certain cancers.

What is the Importance of Timely Treatment?

Early, individualised management of severe obesity can help reduce the risk of type 2 diabetes, cardiovascular disease, high blood pressure, obstructive sleep apnoea, fatty liver disease, osteoarthritis, kidney disease, and other complications. Treatment may also improve mobility, sleep, physical functioning, and quality of life.

What are the Common Symptoms of Morbid Obesity?

• Excessive body weight and increased abdominal fat
• Difficulty walking, climbing stairs, or performing daily activities
• Breathlessness during physical activity
• Snoring or symptoms of obstructive sleep apnea
• Excessive daytime sleepiness or fatigue
• Joint, knee, hip, or back pain
• Reduced physical endurance
• Excessive sweating or heat intolerance
• Skin-fold irritation or recurrent skin infections
• Gastroesophageal reflux symptoms
• Difficulty sleeping
• Reduced mobility or physical independence
• Symptoms related to diabetes, high blood pressure, fatty liver disease, or cardiovascular disease

Causes and Risk Factors of Morbid Obesity

Causes

• Severe obesity usually develops through multiple interacting factors rather than a single cause.
• These may include genetic susceptibility, changes in appetite and energy regulation, dietary patterns, physical inactivity, sleep disorders, psychological and social factors, medications, endocrine disorders, and environmental influences.
• Certain genetic syndromes and medical conditions can cause or contribute to obesity in a smaller proportion of patients.

Risk Factors

• Family history of obesity
• High-calorie or energy-dense dietary patterns
• Physical inactivity
• Sedentary lifestyle
• Sleep deprivation or sleep disorders
• Certain medicines, including some psychiatric, neurological, endocrine, and corticosteroid medicines
• Endocrine disorders such as hypothyroidism or Cushing syndrome
• Insulin resistance and type 2 diabetes
• Psychological and social factors
• Previous unsuccessful weight-loss attempts with subsequent weight regain
• Genetic disorders associated with obesity
• Environmental and socioeconomic factors that limit access to healthy food or physical activity

Latest Research and Technologies in the Treatment of Morbid Obesity in the United Arab Emirates

• Current approaches include structured nutrition and physical-activity programmes, behavioural support, and anti-obesity medicines, including GLP-1 receptor agonists and other incretin-based therapies where approved and clinically appropriate. Clinicians may consider metabolic and bariatric surgery, including sleeve gastrectomy and Roux-en-Y gastric bypass, for eligible patients based on clinical assessment. Treatment selection depends on obesity severity, associated health conditions, previous treatment response, patient preferences, and local availability.